MacroGenics, Inc. (MGNX) vs Niagen Bioscience, Inc. (NAGE)
MacroGenics, Inc. and Niagen Bioscience, Inc. are both Biotechnology companies. MacroGenics, Inc. and Niagen Bioscience, Inc. are of similar size ($242.1M and $238.2M). MacroGenics, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 15.2×. MacroGenics, Inc. grew revenue faster over the last twelve months: 21.9% against 11.0%. Niagen Bioscience, Inc. has the higher net margin (12.4% vs −7.97%) and the higher return on invested capital (42.0% vs 0.00%). Across the 17 metrics below, Niagen Bioscience, Inc. leads on 13 and MacroGenics, Inc. on 4.
Valuation
Profitability
| Metric | MGNX | NAGE | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.07% | 64.24% | 65.16% |
| Operating margin | (18.73%) | 8.21% | 0.00% |
| Net margin | (7.97%) | 12.39% | 0.00% |
| Free cash flow margin | (35.80%) | 8.89% | 0.00% |
| Return on equity | (32.61%) | 21.80% | (57.72%) |
| Return on assets | (4.94%) | 16.14% | (49.22%) |
| Return on invested capital | 0.00% | 41.95% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack